0001474064-12-000059.txt : 20121005
0001474064-12-000059.hdr.sgml : 20121005
20121005160149
ACCESSION NUMBER: 0001474064-12-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121003
FILED AS OF DATE: 20121005
DATE AS OF CHANGE: 20121005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARCEAU ROGER
CENTRAL INDEX KEY: 0001451767
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 121132425
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2012-10-03
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001451767
GARCEAU ROGER
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
SVP & CMO
Common Stock
2012-10-03
4
M
0
140625
5.98
A
140625
D
Common Stock
2012-10-03
4
S
0
140625
9.5084
D
0
D
Stock Option
5.98
2012-10-03
4
M
0
140625
0
D
2009-12-11
2018-12-11
Common Stock
140625
9375
D
The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective December 7, 2011.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was $9.50 and $9.57.
On December 11, 2008, the Reporting Person received a grant of 150,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months on the anniversary date thereafter.
Edward Stratemeier as Attorney-in-fact
2012-10-05